TROSPIUM CHLORIDE | N022103 | ALLERGAN INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition From Alan Laboratories, Inc. FDA-2014-P-2276 Alan Laboratories, Inc. filed this citizen petition under 21 C.F.R. § 10.30 requesting that the FDA designate a second reference listed drug for Sanctura trospium chloride XR 60 mg capsule (NDA 022103) and Sanctura 20 mg tablet (NDA 021595), specifically designating generic products from Actavis Lab | 505(q) | 2014-12-23 | Denied | Alan Laboratories |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.